These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 29745091)

  • 1. Upregulation of miR-191 promotes cell growth and invasion via targeting TIMP3 in prostate cancer.
    Wang X; Shi Z; Liu X; Su Y; Li W; Dong H; Zhao L; Li M; Wang Y; Jin X; Huo Z
    J BUON; 2018; 23(2):444-452. PubMed ID: 29745091
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long non-coding RNA-NEAT1, a sponge for miR-98-5p, promotes expression of oncogene HMGA2 in prostate cancer.
    Guo Z; He C; Yang F; Qin L; Lu X; Wu J
    Biosci Rep; 2019 Sep; 39(9):. PubMed ID: 31481527
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNA-21 promotes proliferation, migration, and invasion of cervical cancer through targeting TIMP3.
    Zhang Z; Wang J; Wang X; Song W; Shi Y; Zhang L
    Arch Gynecol Obstet; 2018 Feb; 297(2):433-442. PubMed ID: 29177591
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LncRNA UCA1 acts as a sponge of miR-204 to up-regulate CXCR4 expression and promote prostate cancer progression.
    He C; Lu X; Yang F; Qin L; Guo Z; Sun Y; Wu J
    Biosci Rep; 2019 May; 39(5):. PubMed ID: 30940776
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A circular RNA, circSMARCA5, inhibits prostate cancer proliferative, migrative, and invasive capabilities via the miR-181b-5p/miR-17-3p-TIMP3 axis.
    Xie X; Sun FK; Huang X; Wang CH; Dai J; Zhao JP; Fang C; He W
    Aging (Albany NY); 2021 Aug; 13(15):19908-19919. PubMed ID: 34390329
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The biological functions and mechanism of miR‑212 in prostate cancer proliferation, migration and invasion via targeting Engrailed-2.
    Zhou Y; Ji Z; Yan W; Zhou Z; Li H
    Oncol Rep; 2017 Sep; 38(3):1411-1419. PubMed ID: 28713997
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNA-132/212 Upregulation Inhibits TGF-β-Mediated Epithelial-Mesenchymal Transition of Prostate Cancer Cells by Targeting SOX4.
    Fu W; Tao T; Qi M; Wang L; Hu J; Li X; Xing N; Du R; Han B
    Prostate; 2016 Dec; 76(16):1560-1570. PubMed ID: 27527117
    [TBL] [Abstract][Full Text] [Related]  

  • 8. miR-152 controls migration and invasive potential by targeting TGFα in prostate cancer cell lines.
    Zhu C; Li J; Ding Q; Cheng G; Zhou H; Tao L; Cai H; Li P; Cao Q; Ju X; Meng X; Qin C; Hua L; Shao P; Yin C
    Prostate; 2013 Jul; 73(10):1082-9. PubMed ID: 23460133
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Upregulation of miR-3195, miR-3687 and miR-4417 is associated with castration-resistant prostate cancer.
    Rönnau CGH; Fussek S; Smit FP; Aalders TW; van Hooij O; Pinto PMC; Burchardt M; Schalken JA; Verhaegh GW
    World J Urol; 2021 Oct; 39(10):3789-3797. PubMed ID: 33990872
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of miR-200c on the migration and invasion abilities of human prostate cancer Du145 cells and the corresponding mechanism.
    Shi R; Xiao H; Yang T; Chang L; Tian Y; Wu B; Xu H
    Front Med; 2014 Dec; 8(4):456-63. PubMed ID: 25363395
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Loss of miR-449a-caused PrLZ overexpression promotes prostate cancer metastasis.
    Chen W; Liu Y; Chen H; Ning H; Ding K
    Int J Oncol; 2017 Aug; 51(2):435-444. PubMed ID: 28627667
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MiR-150 promotes the cell invasion of prostate cancer cells by directly regulating the expression of p53.
    Zhao Y; Zhu Y; Song J
    Pharmazie; 2016 Sep; 71(9):533-536. PubMed ID: 29441850
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Micro-RNA-186-5p inhibition attenuates proliferation, anchorage independent growth and invasion in metastatic prostate cancer cells.
    Jones DZ; Schmidt ML; Suman S; Hobbing KR; Barve SS; Gobejishvili L; Brock G; Klinge CM; Rai SN; Park J; Clark GJ; Agarwal R; Kidd LR
    BMC Cancer; 2018 Apr; 18(1):421. PubMed ID: 29653561
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MiR-203 down-regulates Rap1A and suppresses cell proliferation, adhesion and invasion in prostate cancer.
    Xiang J; Bian C; Wang H; Huang S; Wu D
    J Exp Clin Cancer Res; 2015 Jan; 34(1):8. PubMed ID: 25636908
    [TBL] [Abstract][Full Text] [Related]  

  • 15. miR-564 inhibited metastasis and proliferation of prostate cancer by targeting MLLT3.
    Meng FJ; Meng FM; Wu HX; Cao XF
    Eur Rev Med Pharmacol Sci; 2017 Nov; 21(21):4828-4834. PubMed ID: 29164580
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Down-regulation of miR-605 promotes the proliferation and invasion of prostate cancer cells by up-regulating EN2.
    Zhou YJ; Yang HQ; Xia W; Cui L; Xu RF; Lu H; Xue Z; Zhang B; Tian ZN; Cao YJ; Xing ZY; Yin S; He XZ
    Life Sci; 2017 Dec; 190():7-14. PubMed ID: 28943214
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNA-494-3p targets CXCR4 to suppress the proliferation, invasion, and migration of prostate cancer.
    Shen PF; Chen XQ; Liao YC; Chen N; Zhou Q; Wei Q; Li X; Wang J; Zeng H
    Prostate; 2014 May; 74(7):756-67. PubMed ID: 24644030
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA-487a-3p functions as a new tumor suppressor in prostate cancer by targeting CCND1.
    Wang M; Yu W; Gao J; Ma W; Frentsch M; Thiel A; Liu M; Rahman N; Qin Z; Li X
    J Cell Physiol; 2020 Feb; 235(2):1588-1600. PubMed ID: 31309555
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TUG1 promotes the development of prostate cancer by regulating RLIM.
    Guo BH; Zhao Q; Li HY
    Eur Rev Med Pharmacol Sci; 2019 Mar; 23(5):1926-1933. PubMed ID: 30915735
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor-Suppressive Function of miR-30d-5p in Prostate Cancer Cell Proliferation and Migration by Targeting NT5E.
    Song Y; Song C; Yang S
    Cancer Biother Radiopharm; 2018 Jun; 33(5):203-211. PubMed ID: 29916747
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.